Low Gradient Severe Aortic Stenosis despite Preserved Ejection Fraction

Original title: Invasive Hemodynamic Characteristics of Low Gradient Severe Aortic Stenosis Despite Preserved Ejection Fraction. Reference: Juliane Lauten et al. J Am Coll Cardiol 2013;61:1799–808.

Although the pathophysiology, clinical features, and natural course of severe aortic stenosis have been extensively described, management recommendations are still evolving. The current European and American guidelines recommend a valve area cutoff of 1 cm2, or indexed for body surface area of 0.6 cm2/m2, and a ≥40 mm Hg mean pressure gradient, to identify severe aortic stenosis in the presence of normal cardiac output and preserved ejection fraction. However, in a considerable number of patients with normal cardiac output that present aortic stenosis, these appear to be severe judging by their valve orifice area, but moderate (or even mild) judging by their transvalvular gradients.) Because both values usually derived from echocardiography, these cases with low gradients with 40 mm Hg mean gradient and ≥50% ejection fraction were analyzed by echo; they routinely underwent invasive hemodynamic evaluation with retrograde passage of the aortic valve and calculation of aortic orifice area by the Gorlin formula (stroke volume was measured both by oxymetry or by thermodilution in all patients).

Stroke volumes measured by thermodilution were higher than stroke volumes measured by oxymetry (p < 0.0001). Given this difference, results were compared against echo measurements. In this population, the echo area (0.8 ± 0.15 cm²) correlated modestly compared to the invasive measurement of stroke volumes with oxymetry , (0.69 ± 0.16 cm2, bias 0.14 ± 0.17 cm2) or using thermodilution (0.85 ± 0.19 cm2, bias 0.03 ± 0.19 cm2) Mean gradients were very similar by echo and catheterization, with nonsignificant differences. Reclassification to moderate stenosis by hemodynamics occurred in one patient using oxymetry and in 6 patients using thermodilution.

Conclusion: 

Low gradient severe aortic stenosis despite preserved ejection fraction was confirmed by invasive hemodynamics and was not the result of a systematic bias in echo calculation of the aortic orifice area.

Editorial Comment: 

Although both methods present limitations and the area calculation correlates modestly, patient reclassification, that would eventually change therapeutics, is not frequent, especially when oxymetry is used to calcualte stroke volumen.

SOLACI.ORG

More articles by this author

ACC 2025 | TAVI in Low-Risk Patients: 5-Year Outcomes of EVOLUTE LOW RISK

Transcatheter aortic valve implantation (TAVI) is a valid alternative to surgery in low-risk patients with severe aortic stenosis. However, one of its main limitations...

ACC 2025 | BHF PROTECT-TAVI: Are Cerebral Protection Systems Necessary in TAVI?

TAVI has seen a steady increase in use, though stroke continues to be one of its unwanted complications, mostly ischemic and, less frequently, hemorrhagic. The...

ACC-2025 Congress Second Day Key Studies

BHF PROTECT-TAVI (Kharbanda RK, Kennedy J, Dodd M, et al.)The largest randomized  trial carried out across 33 UK centers between 2020 and 2024, assessing...

Prospective Analysis of the Feasibility of the PASCAL System for Transcatheter Mitral Repair: OneForAll Registry

Courtesy of Dr. Juan Manuel Pérez. Mitral transcatheter edge-to-edge repair (M-TEER) is an effective option for patients with severe mitral regurgitation who are at high...

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Related Articles

SOLACI Sessionsspot_img

Recent Articles

Patients at High Risk of Bleeding After Coronary Angioplasty: Are Risk Assessment Tools ARC-HBR and PRECISE-DAPT Useful?

Patients undergoing coronary stenting typically receive dual antiplatelet therapy (DAPT) for 6 to 12 months, consisting of a P2Y12 receptor inhibitor and aspirin. While DAPT...

ACC 2025 | WARRIOR: Ischemia in Women with Non-Obstructive Coronary Artery Disease

Approximately half of all women with symptomatic ischemia who undergo coronary angiography are found to have non-obstructive coronary artery disease ((ischemia and non-obstructive coronary...

ACC 2025 | TAVI in Low-Risk Patients: 5-Year Outcomes of EVOLUTE LOW RISK

Transcatheter aortic valve implantation (TAVI) is a valid alternative to surgery in low-risk patients with severe aortic stenosis. However, one of its main limitations...